Axsome Therapeutics, Inc. (AXSM)
183.72
-2.46
(-1.32%)
USD |
NASDAQ |
Feb 20, 16:00
183.96
+0.24
(+0.13%)
After-Hours: 20:00
Axsome Therapeutics SG&A Expense (Quarterly) : 150.24M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 123.98M |
| Gilead Sciences, Inc. | 1.794B |
| Vanda Pharmaceuticals, Inc. | 62.98M |
| ACADIA Pharmaceuticals, Inc. | 133.40M |
| Amicus Therapeutics, Inc. | 117.08M |